Table 4.
IVF cycle characteristics and outcomes in endometriosis patients without endometrioma surgery, compared to control group. Values are shown as mean ± SD or percentage (%).
| Non-Endometriosis | Non-Operated Endometrioma | p Value | |
|---|---|---|---|
| (n = 969) | (n= 90) | ||
| AMH (ng/mL) | 3.9 ± 3.9 | 2.6 ± 2.7 | 0.0001 * |
| Antral Follicular Count | 19.6 ± 10.6 | 16.7 ± 11.6 | 0.0004 * |
| Basal FSH (IU/L) | 7.0 ± 2.5 | 8.0 ± 3.0 | 0.009 * |
| Total FSH administered (IU) | 2341.9 ± 985.8 | 2816.6 ± 1130.9 | 0.00005 * |
| Retrieved oocytes (n) | 9.7 ± 6.4 | 7.2 ± 3.9 | 0.0003 * |
| Embryos (n) | 4.8 ± 3.9 | 3.4 ± 2.6 | 0.003 * |
| Top-quality embryos (%) | 16.3 ± 25.2 | 14.8 ± 23.7 | 0.5 |
| Usable embryos (%) | 66.3 ± 28.1 | 62.8 ± 33.4 | 0.4 |
| Implantation rate (%) | 23.6 | 19.1 | 0.3 |
| Live birth rate/cycle (%) | 23.2 | 18.6 | 0.3 |
* significant.